CONTENTS:
- Addiction in China: towards a research agenda for the next 5 years [Editorial]. West R., Hao W., Lam T.H., Lau J., Li J., Li J., et al., p. 1911-1914.
- Mobile telephone-delivered contingency management interventions promoting behaviour change in individuals with substance use disorders: a meta-analysis. Getty C.A., Morande A., Lynskey M., Weaver T., Metrebian N., p. 1915-1925.
- Behavioral economic tobacco demand in relation to cigarette consumption and nicotine dependence: a meta-analysis of cross-sectional relationships. Gonzalez-Roz A., Jackson J., Murphy C., Rohsenow D.J., MacKillop J., p. 1926-1940.
- Drug Policy and the Public Good: a summary of the second edition. Babor T.F., Caulkins J., Fischer B., Foxcroft D., Medina-Mora M.E., Obot I., et al., p. 1941-1950.
- Cytisine for nicotine addiction treatment: a review of pharmacology, therapeutics and an update of clinical trial evidence for smoking cessation. Tutka P., Vinnikov D., Courtney R.J., Benowitz N.L., p. 1951-1969.
- The collectivity of British alcohol consumption trends across different temporal processes: a quantile age-period-cohort analysis. Holmes J., Ally A.K., Meier P.S., Pryce R., p. 1970-1980.
- Elevated maternal and child mortality among women with multiple DUI convictions compared with socio-demographically matched controls. McCutcheon V.V., Bucholz K.K., Houston-Ludlam A.N., Heath A.C., p. 1981-1991.
- Buprenorphine prescribing for opioid use disorder in medical practices: can office-based out-patient care address the opiate crisis in the United States? Rhee T.G., Rosenheck R.A., p. 1992-1999.
- Circumstances of death of opioid users being treated with naltrexone. Darke S., Farrell M., Duflou J., Larance B., Lappin J., p. 2000-2007.
- Association between opioid use disorder and fractures: a population-based study. Hsu W.Y., Lin C.L., Kao C.H., p. 2008-2015.
- Prescription opioid availability and opioid overdose-related mortality rates in Medicaid expansion and non-expansion states. Swartz J.A., Beltran S.J., p. 2016-2025.
- Expenditure on smoking and alternative nicotine delivery products: a population survey in England. Jackson S.E., Shahab L., Kock L., West R., Brown J., p. 2026-2036.
- Enhanced smoking cessation support for newly abstinent smokers discharged from hospital (the Hospital to Home trial): a randomized controlled trial. Thorley R., Britton J., Nyakutsikwa B., Opazo Breton M., Lewis S.A., Murray R.L., p. 2037-2047.
- Patterns and predictors of e-cigarette, cigarette and dual use uptake in UK adolescents: evidence from a 24-month prospective study. Conner M., Grogan S., Simms-Ellis R., Scholtens K., Sykes-Muskett B., Cowap L., et al., p. 2048-2055.
- Predictors of long-term abstinence rate by income level in the Korean smoking cessation programme. Seo Y.G., Paek Y.J., Jo M.W., Choi J., p. 2056-2064.
- Psychostimulant use and the brain. Lappin J.M., Sara G.E., p. 2065-2077.
- Effectiveness of an offer of the Smoke Free smartphone application for smoking cessation: protocol for a randomized controlled trial. Jackson S.E., Perski O., Crane D., Michie S., West R., Brown J., p. 2078-2086.